Search for: "Global Pharmaceuticals, LLC" Results 1 - 20 of 267
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jun 2023, 10:08 am by Stoltmann Law
San Francisco, California, USA, June 14, 2023 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an affiliate of US Capital Global, is offering eligible investors an investment opportunity of up to $5 million in Andira Pharmaceuticals (“Andira” or the “Company”). [read post]
28 Apr 2016, 11:09 am by Fraud Fighters
The merger, which was largely backed by Wall Street, established Pfizer’s global dominance in the pharmaceutical industry, and it was estimated that the acquisition would save the company $4 billion annually. [read post]
24 Feb 2013, 9:06 pm by Patent Docs
Reddy's Laboratories Ltd.; Emcure Pharmaceuticals USA, Inc.; Emcure Pharmaceuticals USA, Inc.; Hospira, Inc.; Pharmaceutics International Inc.; Pharmaforce, Inc.; Sagent Pharmaceuticals, Inc.; ACS DOBFAR Info S.A.; Strides, Inc.; Agila Specialities Private Ltd.; Sun Pharmaceuticals Industries, Inc.; Sun Pharma Global FZE;... [read post]
8 Jan 2012, 9:05 pm by Patent Docs
Mylan, Inc. et al. 1:12-cv-00024; filed January 3, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc.; Takeda Global Research and Development Center, Inc.; Watson Pharmaceuticals, Inc.; Andrx Labs, LLC • Defendants: Mylan, Inc.; Mylan Pharmaceuticals, Inc. [read post]
30 Aug 2009, 9:43 pm
LLC • Defendants: Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd. [read post]
24 Mar 2011, 10:12 am by FDABlog HPM
Dormer, Hyman, Phelps & McNamara, P.C., United StatesAtsushi Hakoda, Nakamura & Partners, JapanJuany Huang, Panawell and Partners LLC, ChinaReuben E. [read post]
11 Jul 2012, 12:49 pm by Cynthia Marcotte Stamer
Pharmaceutical companies will need to carefully study and consider how to react to “groundbreaking” business practice reforms global health care giant GlaxoSmithKline LLC (“GSK”) has agreed to implement as part of the record $3 billion criminal and civil agreement resolving federal health care fraud and drug marketing charges following its July 2, 2012 guilty plea in U.S. v. [read post]
11 Jul 2012, 12:49 pm by Cynthia Marcotte Stamer
Pharmaceutical companies will need to carefully study and consider how to react to “groundbreaking” business practice reforms global health care giant GlaxoSmithKline LLC (“GSK”) has agreed to implement as part of the record $3 billion criminal and civil agreement resolving federal health care fraud and drug marketing charges following its July 2, 2012 guilty plea in U.S. v. [read post]
11 Jul 2012, 12:49 pm by Cynthia Marcotte Stamer
Pharmaceutical companies will need to carefully study and consider how to react to “groundbreaking” business practice reforms global health care giant GlaxoSmithKline LLC (“GSK”) has agreed to implement as part of the record $3 billion criminal and civil agreement resolving federal health care fraud and drug marketing charges following its July 2, 2012 guilty plea in U.S. v. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
Sun Pharmaceutical Industries, Inc., Sun Pharma Global FZE and Caraco Pharmaceutical Laboratories Ltd. [read post]
10 Apr 2017, 5:45 pm by Lawrence B. Ebert
SUN PHARMA GLOBAL FZE [RULE 36 JUDGMENT]ETHOX CHEMICALS, LLC v. [read post]
3 Jan 2013, 11:11 am by Geoff Cockrell
Warburg Pincus acquired JHP Pharmaceuticals from JHP Holdings LLC, an entity majority-owned by Morgan Stanley Principal Investments. [read post]
21 Nov 2008, 5:49 am
By Donald Zuhn -- On Tuesday, Alex Brill (at right), a principal at Matrix Global Advisors, LLC and former chief economist to the House Ways and Means Committee, released a white paper which asserts that a follow-on biologics regulatory pathway providing a data exclusivity period of seven years would be "sufficient for maintaining strong incentives to innovate while fostering a competitive marketplace. [read post]
The world’s largest manufacturer of generic pharmaceuticals, Israeli-based Teva Pharmaceutical Industries Ltd. [read post]
9 Aug 2012, 11:29 am by N. Peter Rasmussen
The SEC separately charged another pharmaceutical company that Pfizer acquired in 2009, Wyeth LLC, with additional FCPA violations.Pfizer and Wyeth agreed to separate settlements in which they will pay more than $45 million combined to settle their respective charges. [read post]
17 Mar 2022, 10:54 am by Jonathan Stroud
” Intel and Xilinx combined to cancel a number of litigation-funded chip patents from Arbor Global Strategies and FG SRC LLC [the latter funded by Freeman Capital Partners]; a number of Fortress-funded subsidiaries were challenged; another 29 IP Edge subsidiary suits; some interesting pharmaceutical action; and companies WebRoot and OpenText, inc. have launched a new assertion campaign against Trend Micro, Kapersky Labs, CrowdStrike, and Sophos on cybersecurity… [read post]
28 Aug 2009, 8:11 am
Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Inc., Sun Pharma Global FZE, Caraco Pharmaceutical Laboratories Ltd. [read post]
17 Jul 2014, 10:58 am
USA; Accord Healthcare, Inc.; Intas Pharmaceuticals Ltd.; Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York, LLC; Amneal Pharmaceuticals Co. [read post]
19 Feb 2019, 1:51 pm by Silver Law Group
(CRD #21786), Chicago Investment Group, LLC (CRD #11853, expelled by FINRA on 9/14/2010) and Eastbrook Capital Group LLC (CRD #39781, expelled by FINRA on 9/23/2009), all of New York City. [read post]
17 Mar 2014, 11:03 am
.; Intas Pharmaceuticals Ltd.; Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York, LLC; Amneal Pharmaceuticals Co. [read post]